The WACC of Supernus Pharmaceuticals Inc (SUPN) is 6.1%.
| Range | Selected | |
| Cost of equity | 7.90% - 10.30% | 9.10% |
| Tax rate | 24.20% - 25.70% | 24.95% |
| Cost of debt | 4.00% - 4.50% | 4.25% |
| WACC | 5.4% - 6.8% | 6.1% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.87 | 0.97 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.90% | 10.30% |
| Tax rate | 24.20% | 25.70% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 4.00% | 4.50% |
| After-tax WACC | 5.4% | 6.8% |
| Selected WACC | 6.1% | |